|1.||Kalofonos, Haralabos P: 4 articles (12/2014 - 10/2010)|
|2.||Zhang, Jie: 4 articles (03/2010 - 12/2005)|
|3.||Xu, Weizheng: 4 articles (03/2010 - 12/2005)|
|4.||Nixon, Joshua P: 3 articles (10/2015 - 08/2012)|
|5.||Butterick, Tammy A: 3 articles (10/2015 - 08/2012)|
|6.||Kotz, Catherine M: 3 articles (10/2015 - 08/2012)|
|7.||Billington, Charles J: 3 articles (10/2015 - 08/2012)|
|8.||Velasco, R: 3 articles (05/2015 - 12/2012)|
|9.||Bruna, J: 3 articles (05/2015 - 12/2012)|
|10.||Alberti, Paola: 3 articles (12/2014 - 12/2012)|
04/01/2015 - "(3) The survival time of tumor-bearing nude mice was dramatically improved in CWQ and CWQ/OXA group. "
03/01/2013 - "The expression levels of sCLU affected the therapeutic efficacy of OXA to treat HCC tumors established in immunodeficiency mice. "
12/02/2013 - "HaT-GEM and HaT-OXA both displayed improved drug uptake in the heated tumor relative to the unheated tumor (by 9-fold and 3-fold, respectively). "
07/01/2014 - "Moreover, in nude mice model, tumor growth was significantly suppressed in the group treated with TPL in combination with OXA. "
12/01/2011 - "Oxa in binary combination with Col and Tax showed the highest synergism in both the cancer cell lines, when administered 4 h after the phytochemical, with CI at ED(50) ranging from 0.004 to 0.1. "
|2.||Colorectal Neoplasms (Colorectal Cancer)
01/01/2010 - "Randomized controlled trials (RCTs) or quasi-RCTs comparing IRI versus OXA, in combination with 5-FU/LV in the treatment of advanced colorectal cancer were performed. "
07/01/2006 - "This study provides the basis for further evaluation of these putative markers of OXA response and resistance in colorectal cancer patients who are candidates for treatment with OXA."
07/01/2015 - "OXA can induce autophagy of colorectal cancer cells, while ASPP2 over-expression can suppress the OXA-induced autophagy. "
01/01/2010 - "Compared with IRI, OXA is more appropriate for the treatment of advanced colorectal cancer when combined with 5-FU/LV. "
05/01/2015 - "A testing protocol with the Thermal Sensory Analyzer (Medoc) was carried out in 20 colorectal cancer patients during the initial four cycles of OXA-based chemotherapy and in 20 age- and sex-matched healthy volunteers. "
|3.||Stomach Neoplasms (Stomach Cancer)
06/01/2013 - "All gastric cancer patients examined in the study received an OXA/5‑fluorouracil chemotherapeutic regimen. "
10/14/2011 - "Immunohistochemical analysis demonstrated that treatment with rAd-p53 alone, OXA alone or combined treatment led to decreased Bcl-2 expression and increased Bax expression in gastric cancer cells. "
10/14/2011 - "Treatment with rAd-p53 or OXA alone inhibited gastric cancer cell growth in a time- and dose-dependent manner; moreover, significant synergistic effects were observed when these treatments were combined. "
12/15/2009 - "Clinical trials of OXA-based chemotherapy (treatment group) versus DDP-based chemotherapy (control group) in advanced gastric cancer which published in 6 years were retrieved from China National Knowledge Infrastructure (CNKI), Wanfang Data, VIP information database and PubMed of U.S. "
12/15/2009 - "To analyze whether Oxaliplatin (OXA) is effective in advanced gastric cancer. "
01/01/2008 - "Both chemicals significantly reduced symptoms of fungal infection, but MJ was more effective than OxA (51 versus 18% reduction in length of necrotic lesions in the phloem relative to untreated control trees). "
03/01/1997 - "LOXA produced a significant reduction of the worm burden compared to the other preparations, when inoculated by subcutaneous route (s.c.) with 10 mg OXA/kg animal one day before the infection, and 3, 7, and 14 days after. "
03/01/1997 - "OXA, in the free form, was effective in relation to the untreated group, only when administered 3 days after the infection. "
12/01/2015 - "The changing epidemiology of Acinetobacter spp. producing OXA carbapenemases causing bloodstream infections in Brazil: a BrasNet report."
01/01/2014 - "Detection of OXA-1 β-lactamase gene of Klebsiella pneumoniae from blood stream infections (BSI) by conventional PCR and in-silico analysis to understand the mechanism of OXA mediated resistance."
|5.||Colonic Neoplasms (Colon Cancer)
01/01/2003 - "The main objective of this experimental study was to examine the cytotoxic effects resulting from the addition of ionizing radiation (Rgamma) to the combination OXA-FUFA on 2 human colon cancer cell lines (SW403, p53 wild type and WiDr, p53 mutated). "
07/01/2014 - "In conclusion, our result revealed that the combination therapy with TPL and OXA exerted synergistic antitumor effects at low concentration in colon cancer cells, with less cytotoxity, which exhibited high potency for clinical applications."
07/01/2014 - "The results demonstrated that combination therapy of TPL and OXA could effectively inhibit the proliferation of colon cancer cell line SW480 and induce cell apoptosis of colon cancer cells. "
01/01/2008 - "Thus, we investigated whether FUL in combination with OXA according to 2 different schedules may influence CEA expression in human colon cancer cells in vitro. "
07/01/2014 - "Cell viability was measured by MTT assay and cell apoptosis rate was analyzed by FACS assay after treatment with TPL and OXA alone, and TPL combined with OXA in colon cancer cell line SW480. "
|3.||Leucovorin (Folinic Acid)
|2.||Drug Therapy (Chemotherapy)
|3.||Heterologous Transplantation (Xenotransplantation)
|5.||Continuous Ambulatory Peritoneal Dialysis (CAPD)